Thursday, October 26, 2023 8:07:34 AM
Announcement follows launch of Affiliate Program to Drive Further Awareness and Growth
Dallas, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is excited to announce the official launch of the Company’s new TikTok and Instagram Social Media Influencer Initiative, featuring top relevant influencers with vast global fan bases on the world’s leading social media platforms.
After initial traction, the Company is ramping up its exposure by working to deepen its connection with the wildly popular Barstool Sports brand and Glenny Balls, famous American Podcaster, Blogger, TV personality, and Influencer on the Barstool Sports team as a top influencer. MangoRx has been a key sponsor of Barstool Sports podcasts since June 2023. This new step serves to deepen that relationship.
Furthermore, management notes that this is just the first step in the process of ramping up the Company’s footprint with leading relevant influencers on Instagram and TikTok.
Barstool Sports is one of the most widely followed influencer brands in the men’s health space, pulling in 15 million followers on Instagram and 33.3 million more on TikTok. Glenny Balls, through his own brand, has cultivated an audience of over 300k on Instagram and more than 243k on TikTok. In the immediate future, the Company will focus on tapping into Glenny Balls and his powerful audience reach to promote the MangoRx brand through the Old Row TikTok account (www.tiktok.com/@oldrowofficial).
“Our relationship with Barstool Sports and Glenny Balls is a powerful conduit to tap directly into our end market and connect with our most important cohort,” remarked Jacob Cohen, CEO and Co-Founder of MangoRx. “We are signing up leading influencers on the two most powerful social media platforms in the world right now and this is just the start. We are ready to launch our presence across these platforms at this point because our product line, our branding, and our messaging are all ready for that level of exposure. We plan to ramp up this facet of our marketing strategy aggressively going forward, with a series of new tier-one influencers coming on board over the following weeks. This is just the beginning.”
About Mango
Created using a special formulation featuring either the same active ingredient as in Cialis™ (Tadalafil) or Viagra™ (Sildenafil), each part of the Mango formulation plays a critical role in helping men achieve optimum performance. We believe the key to our success lies in our unique blend of ingredients, which are used in U.S. Food and Drug Administration (“FDA”) approved drugs. Mango contains a combination of either Sildenafil or Tadalafil along with Oxytocin and L-Arginine that have been traditionally used to treat sexual dysfunction.
Mango is a prescription medication that must be approved by a physician. After an individual has completed an online tele-health visit, our network of medical providers will review and approve a prescription if medically appropriate. Mango is a rapidly dissolved tablet (RDT) that is absorbed orally. For best results, we advise taking Mango at least 15 minutes before engaging in sexual activity. Sildenafil and Tadalafil, one of the main ingredients in Mango, typically have effects that last up to 4 and 36 hours, respectively.
About Mangoceuticals
Mangoceuticals, Inc. is a company focused on developing, marketing, and selling a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED). The Company has developed a new brand of ED product under the brand name "Mango" (think: "Man, Go!").
To participate in the Mango Revenue affiliate marketing program, please visit: https://mangorevenue.com.
For more information, please visit www.MangoRx.com.
Cautionary Note Regarding Forward-Looking Statements
Certain statements made in this press release contain forward-looking information within the meaning of applicable securities laws, including within the meaning of the Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). These forward-looking statements represent the Company's current expectations or beliefs concerning future events and can generally be identified using statements that include words such as "estimate," "expects," "project," "believe," "anticipate," "intend," "plan," "foresee," "forecast," "likely," "will," "target" or similar words or phrases. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of the Company's control which could cause actual results to differ materially from the results expressed or implied in the forward-looking statements, including, but not limited to; our ability to obtain additional funding and generate revenues to support our operations; risks associated with ou
Recent MGRX News
- Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access • GlobeNewswire Inc. • 07/18/2024 08:05:00 PM
- MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts • GlobeNewswire Inc. • 07/16/2024 12:20:00 PM
- MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department • GlobeNewswire Inc. • 07/12/2024 05:30:00 PM
- MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets • GlobeNewswire Inc. • 07/11/2024 12:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 06:57:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 05:28:45 PM
- MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:24 PM
- MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies • GlobeNewswire Inc. • 06/04/2024 08:00:00 PM
- MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications • GlobeNewswire Inc. • 05/21/2024 12:30:00 PM
- MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration • GlobeNewswire Inc. • 05/16/2024 08:40:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/16/2024 05:59:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/16/2024 01:19:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:52:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2024 01:00:58 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/06/2024 09:32:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/06/2024 08:43:00 PM
- Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM